Exclusion Criteria:~* Non-AD dementia~* Residence in a long-term care facility at baseline~* History of
clinically significant stroke~* Modified Hachinski Ischemia score â‰¥ 4~* Current evidence or history in past two
years of epilepsy, seizure, focal brain lesion, head injury with loss of consciousness or DSM-IV (Diagnostic
and Statistical Manual of Mental Disorders, Fourth Edition) criteria for any major psychiatric disorder
including psychosis, major depression, bipolar disorder, alcohol or substance abuse~* Sensory impairment which
would prevent subject from participating in or cooperating with the protocol~* Use of another investigational
agent within two months~* Evidence of any significant clinical disorder or laboratory finding that renders the
participant unsuitable for receiving an investigational new drug including clinically significant or unstable
hematologic, hepatic, cardiovascular (including history of ventricular fibrillation or ventricular
tachycardia), pulmonary, gastrointestinal, endocrine, metabolic, renal, or other systemic disease or laboratory
abnormality~* Active neoplastic disease (skin tumors other than melanoma may be included; participants with
stable prostate cancer may be included at the discretion of the Project Director)
